• Support for expansion of the Medicare Diabetes Prevention Program (DPP). Medicare reimbursement issues. Issues regarding privacy. Health information technology issues. HR 7190/S. 3951 - Increasing Rural Health Access During the COVID-19 Public Health Emergency Act of 2020. H.R. 925, the Heroes Act. H.R. 133, Consolidating Appropriations Act, 2021. S. 4709, A bill to permit Centers for Disease Control and Prevention-recognized virtual diabetes prevention program suppliers to be included in the Medicare Diabetes Prevention Program Expanded Model conducted by the Center for Medicare and Medicaid Innovation under section 1115A of the Social Security Act (42 U.S.C. 1315a).
• Support for expansion of the Medicare Diabetes Prevention Program (DPP). Medicare reimbursement issues. Issues regarding privacy. Health information technology issues. H.R. 133, Consolidating Appropriations Act, 2021. H.R. 925, the Heroes Act.

Duration: December 1, 2019 to November 30, 2020

General Issues: Health Issues, Medicare/Medicaid

Spending: about $220,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2019: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Office of Personnel Management (OPM)